Interpretation of the consensus of Chinese experts on gut microbiota and fecal microbiota transplantation in inflammatory bowel disease (2025 edition)

VernacularTitle:《肠菌移植治疗炎症性肠病专家共识（2025版）》解读
Author: Di ZHAO ¹ ; Qiyi CHEN ; Huanlong QIN
Author Information

1. 同济大学附属第十人民医院普通外科　功能肠道外科，上海　200072
Publication Type:Journal Article
Keywords: Inflammatory bowel disease; Fecal microbiota transplantation; Expert consensus
From: Chinese Journal of Inflammatory Bowel Diseases 2025;09(2):103-107
CountryChina
Language:Chinese
Abstract: In recent years, fecal microbiota transplantation (FMT) has shown significant progress in the research and treatment of inflammatory bowel disease (IBD). However, challenges remain in evaluating its efficacy and clinical adoption due to methodological heterogeneity. Since 2023, Europe, the United States, and China have issued a series of guidelines and consensus statements on FMT for IBD, addressing its background, therapeutic goals, and principles. The 2025 Chinese consensus on FMT for IBD integrates the experience of China's largest FMT treatment center and the latest global evidence, with a focus on standardizing FMT methodologies. This article highlights key methodological aspects from the consensus and compares them with recent international guidelines, aiming to enhance clinicians' understanding of FMT principles, advance clinical practice, and promote standardized and evidence-based FMT applications in IBD management.